VC  Telegraph Hill Partners

https://thpartners.net/





     Office Locations:

360 Post Street, Suite 601
San Francisco, CA 94108
Phone: 415-765-6980
Fax: 415-765-6983

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded 2001, Telegraph Hill Partners (THP) is a venture capital and growth equity firm dedicated to building life science and healthcare technology businesses. The firm targets commercial companies in growth areas within the healthcare sector, including life science technologies, medical devices, chemistry and reagent suppliers, healthcare services and information management. THP typically invests $2-8 million in portfolio companies. The firm targets companies that are beyond development stage and have entered the commercialization phase with quality products and a focus on building revenues and profits. Telegraph Hill announced (July 2022) that it has closed on THP V, a new $525 million investment fund.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Deval A. Lashkari PhD Senior Partner
    Gary D. Curtis Venture Partner
    J. Matthew Mackowski Chairman, Managing Director
    Jeanette M. Welsh JD Partner, Chief Operating Officer
    Rob C. Hart Partner

     

    Portfolio companies include:


      AltheaDx


      Aquaro Histology
        web link


      Argonaut


      Asuragen


      Carterra


      Cell Microsystems


      Dynex


      ETS


      Specific Diagnostics
        web link


     

    Recent News: